DSpace Repository

The impact of new drug launches on the loss of labor from disease and injury: evidence from German panel data

Show simple item record

dc.creator Bui, Thi Mai Van
dc.creator Stolpe, Michael
dc.date 2007
dc.date.accessioned 2013-10-16T06:12:38Z
dc.date.available 2013-10-16T06:12:38Z
dc.date.issued 2013-10-16
dc.identifier http://hdl.handle.net/10419/3998
dc.identifier ppn:527773581
dc.identifier.uri http://koha.mediu.edu.my:8181/xmlui/handle/10419/3998
dc.description This paper studies the evolution of early retirement due to disease and injury in the German labor force between 1988 and 2004. Using data from the German Federation of Public Pension Providers, the IMS Health Drug Launches database and the WHO Mortality Database, we show that new drug launches have substantially helped to reduce the loss of labor at the disease-level over time. We employ a variety of econometric methods to exploit the pseudo-panel structure of our dataset and find that in Western Germany alone each new chemical entity has on average saved around 200 working years in every year of the observation period. Controlling for individual determinants of health-related retirement, such as worker?s age, sex and type of work, we also find evidence that the 2001 reform of pension laws has led to further reductions in the loss of labor from disease and injury.
dc.language eng
dc.publisher Kiel Institute for the World Economy (IfW) Kiel
dc.relation Kieler Arbeitspapiere 1317
dc.rights http://www.econstor.eu/dspace/Nutzungsbedingungen
dc.subject I18
dc.subject J26
dc.subject I12
dc.subject ddc:330
dc.subject Medical technology
dc.subject Early retirement
dc.subject Rehabilitation services
dc.subject Pension reform
dc.subject Pseudo-panel data
dc.subject Flexible Altersgrenze
dc.subject Erwerbsunfähigkeit
dc.subject Pharmazeutisches Produkt
dc.subject Technischer Fortschritt
dc.subject Ältere Arbeitskräfte
dc.subject Arbeitsangebot
dc.subject Rentenreform
dc.subject Gesundheit
dc.subject Schätzung
dc.subject Deutschland
dc.title The impact of new drug launches on the loss of labor from disease and injury: evidence from German panel data
dc.type doc-type:workingPaper


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account